Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of ECP on intestinal immune cells in immune checkpoint inhibitor-induced colitis - batch2 [scRNA-Seq]

ABSTRACT: Effect of ECP on intestinal immune cells in immune checkpoint inhibitor-induced colitis - batch2 [scRNA-Seq]

PROVIDER: PRJNA1078864 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28037786_1.fastq.gz	Fastqsanger.gz
	SRR28037786_2.fastq.gz	Fastqsanger.gz
	SRR28037787_1.fastq.gz	Fastqsanger.gz
	SRR28037787_2.fastq.gz	Fastqsanger.gz
	SRR28037788_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Effect of ECP on intestinal immune cells in immune checkpoint inhibitor-induced colitis - batch2 [scRNA-Seq]

Project description:Immune Checkpoint Inhibitors (ICI) have proven to be beneficial against tumors by boosting anti-tumor immunity, however these therapies can induce severe inflammatory side effects in all tissues, named immune-related adverse events (irAE). The colon is affected most commonly. These cause termination of treatment. Until today, patients with irAEs received systemic immunosuppressive therapies. We have found ECP as a novel therapy, which causes immunomodulation in the inflamed tissue without systemic immunosuppression. To understand which immune cells are affected by ECP in the inflamed intestinal tract, mice were treated with DSS and anti-PD1 to induce colitis, comparable to patients suffering from ICI-induced irAEs. ECP showed beneficial effects in patients. Mice were transplanted with ECP-treated cells as treatment and scSeq was performed with Colon infiltrating CD45 positive cells. Naive mice, mice receiving DSS and isotype control and mice receiving DSS in combination with anti-PD1 and untreated splenocytes, served as control.

2024-11-27 | GSE256286 | GEO

ECP as a treatment for immune checkpoint inhibitor-induced colitis [array]

Project description:Mice were treated with DSS and anti-PD1 to induce colitis, comparable to patients suffering from ICI-induced immune-related adverse events. ECP showed beneficial effects in patients. Mice were transplanted with ECP-tretaed cells as treatment and RNA was extracted from colitis tissue to anravel the mechanisms causing the reduction of colitis severity.

2024-11-27 | GSE207823 | GEO

Immune checkpoint inhibitor-induced colitis

Project description:Immune checkpoint inhibitor-induced colitis

| PRJNA857579 | ENA

Effect of ECP on intestinal immune cells immune checkpoint inhibitor-induced colitis [scRNA-Seq]

Project description:Mice were treated with DSS and anti-PD1 to induce colitis, comparable to patients suffering from ICI-induced immune-related adverse events. ECP showed beneficial effects in patients. Mice were transplanted with ECP-tretaed cells as treatment and scSeq was performed with Colon infiltrating CD45 positive cells.

2024-11-27 | GSE207883 | GEO

ECP as a treatment for immune checkpoint inhibitor-induced colitis [array]

Project description:ECP as a treatment for immune checkpoint inhibitor-induced colitis [array]

| PRJNA857291 | ENA

Effect of ECP on intestinal immune cells immune checkpoint inhibitor-induced colitis [scRNA-Seq]

Project description:Effect of ECP on intestinal immune cells immune checkpoint inhibitor-induced colitis [scRNA-Seq]

| PRJNA857581 | ENA

Colitis associated with immune checkpoint inhibitors

Project description:Colitis associated with immune checkpoint inhibitors

| PRJNA849977 | ENA

Colitis associated with immune checkpoint inhibitors [tissue_nuclei]

Project description:Colitis associated with immune checkpoint inhibitors [tissue_nuclei]